San Francisco-based Invitae Corp, a genetic information company, has announced that its testing services are eligible for coverage by two additional payors, Blue Shield of California and the Centers for Medicare and Medicaid Services (CMS).
Invitae’s mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people.
“Securing reimbursement is an important step towards realizing our mission to make genetic testing affordable and accessible for patients,” says Lisa Alderson, chief commercial officer of Invitae. “Since launching just over a year ago, we have grown our volume rapidly by offering high-quality genetic testing at an affordable price for payors.”
Invitae currently offers clinicians an assay of 216 genes comprising 85 different genetic disorders and 17 targeted panels focused on hereditary cancers, including breast, ovarian, colon, and pancreatic cancer, as well as cardiology, hematology, neurology, and pediatric panels. The firm presently allows physicians a free re-requisition of additional data within the same indication when ordered within 90 days of the date of service. Importantly, Invitae provides turnaround time of less than 3 weeks for the substantial majority of its tests.
For further information, visit Invitae Corp.